Cash flow HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:07 2025-01-13 am EST			5-day change	1st Jan Change
181.00 ^CHF	-4.13%		+0.22%	+2.84%

Jan. 05	HBM Healthcare Investments Reports Rise in FY25 Nine-month NAV	MT
Dec. 19	HBM Healthcare Investments' Sai Life Sciences Completes India IPO	MT

0b21f9f.5ntCYWEn0hlxCVdpo6gPcAjof9VXvqPdpCngiTTbI1w.kAodVVdXnnciRyVQzfh7QWayHOIG7pqz-2yG3wOZQjuRAg5ROWulSwRQPA

Published financial data: HBM HEALTHCARE INVESTMENTS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Gain (Loss) on Sale of Investment, Total (Rev)	129M	710M	-124M	-214M	-122M
Interest And Invest. Income (Rev)	60M	59M	50M	71.5M	125M
Other Revenues, Total	-	-	-	-	-
Total Revenues	189M	769M	-73.78M	-142M	2.98M
Gross Profit	189M	769M	-73.78M	-142M	2.98M
Selling General & Admin Expenses, Total	2.57M	9.3M	750K	705K	1.6M
Other Operating Expenses	923K	742K	781K	716K	858K
Other Operating Expenses, Total	3.49M	10.04M	1.53M	1.42M	2.46M
Operating Income	185M	759M	-75.31M	-144M	520K
Interest Expense, Total	-2.44M	-2.47M	-2.72M	-2.65M	-1.7M
Interest And Investment Income	1K	-	-	-	94K
Net Interest Expenses	-2.43M	-2.47M	-2.72M	-2.65M	-1.6M
Currency Exchange Gains (Loss)	-	-	-	-	-
EBT, Excl. Unusual Items	183M	756M	-78.03M	-146M	-1.08M
EBT, Incl. Unusual Items	183M	756M	-78.03M	-146M	-1.08M
Earnings From Continuing Operations	183M	756M	-78.03M	-146M	-1.08M
Net Income to Company	183M	756M	-78.03M	-146M	-1.08M
Net Income - (IS)	183M	756M	-78.03M	-146M	-1.08M
Net Income to Common Incl Extra Items	183M	756M	-78.03M	-146M	-1.08M
Net Income to Common Excl. Extra Items	183M	756M	-78.03M	-146M	-1.08M
Per Share Items
Net EPS - Basic	26.26	108.71	-11.22	-21.03	-0.16
Basic EPS - Continuing Operations	26.26	108.71	-11.22	-21.03	-0.16
Basic Weighted Average Shares Outstanding	6.96M	6.96M	6.96M	6.96M	6.93M
Net EPS - Diluted	26.26	108.71	-11.22	-21.03	-0.16
Diluted EPS - Continuing Operations	26.26	108.71	-11.22	-21.03	-0.16
Diluted Weighted Average Shares Outstanding	6.96M	6.96M	6.96M	6.96M	6.93M
Normalized Basic EPS	16.41	67.94	-7.01	-13.14	-0.1
Normalized Diluted EPS	16.41	67.94	-7.01	-13.14	-0.1
Dividend Per Share	7.7	9.5	9.7	7.5	7.5
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITA	185M	759M	-75.31M	-144M	520K
EBIT	185M	759M	-75.31M	-144M	520K
Total Revenues (As Reported)	189M	769M	-73.78M	-142M	2.98M
Normalized Net Income	114M	473M	-48.77M	-91.45M	-677K
Interest on Long-Term Debt	2.4M	2.5M	2.6M	2.65M	1.3M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	6.1M	6.03M	5.39M	5.73M	10.23M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	6.1M	6.03M	5.39M	5.73M	10.23M
Accounts Receivable, Total	27K	17K	20K	16K	60K
Total Receivables	27K	17K	20K	16K	60K
Total Current Assets	6.12M	6.05M	5.41M	5.75M	10.29M
Long-term Investments	1.55B	2.26B	2.13B	1.92B	1.8B
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	1.55B	2.26B	2.14B	1.92B	1.81B
Liabilities
Accrued Expenses, Total	1.58M	8.15M	-	-	-
Current Portion of Long-Term Debt	-	49.97M	-	49.98M	-
Other Current Liabilities	2.25M	2.47M	2.04M	2.17M	3.31M
Total Current Liabilities	3.82M	60.59M	2.04M	52.15M	3.31M
Long-Term Debt	99.56M	49.8M	149M	99.21M	99.39M
Total Liabilities	103M	110M	151M	151M	103M
Common Stock, Total	345M	291M	204M	136M	84.22M
Retained Earnings	963M	1.72B	1.64B	1.49B	1.49B
Treasury Stock	-402K	-402K	-402K	-402K	-15.99M
Comprehensive Income and Other	142M	142M	142M	142M	142M
Total Common Equity	1.45B	2.15B	1.99B	1.77B	1.7B
Total Equity	1.45B	2.15B	1.99B	1.77B	1.7B
Total Liabilities And Equity	1.55B	2.26B	2.14B	1.92B	1.81B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6.96M	6.96M	6.96M	6.96M	6.87M
ECS Total Common Shares Outstanding	6.96M	6.96M	6.96M	6.96M	6.87M
Book Value / Share	208.25	309.25	285.53	254.8	248.1
Tangible Book Value	1.45B	2.15B	1.99B	1.77B	1.7B
Tangible Book Value Per Share	208.25	309.25	285.53	254.8	248.1
Total Debt	99.56M	99.77M	149M	149M	99.39M
Net Debt	93.47M	93.74M	144M	143M	89.16M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	183M	756M	-78.03M	-146M	-1.08M
Other Operating Activities, Total	-187M	-759M	67.83M	145M	-622K
Cash from Operations	-4.16M	-3.23M	-10.2M	-1.29M	-1.7M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	60M	59M	50M	71.5M	125M
Cash from Investing	60M	59M	50M	71.5M	125M
Long-Term Debt Issued, Total	-	-	98.9M	-	-
Total Debt Issued	-	-	98.9M	-	-
Long-Term Debt Repaid, Total	-	-	-50M	-	-50M
Total Debt Repaid	-	-	-50M	-	-50M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-52.18M	-53.57M	-86.96M	-67.48M	-66.5M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-2.27M	-2.27M	-2.39M	-2.38M	-2.3M
Cash from Financing	-54.45M	-55.84M	-40.45M	-69.87M	-119M
Foreign Exchange Rate Adjustments	1K	-	-	-	-
Net Change in Cash	1.39M	-63K	-645K	344K	4.5M
Supplemental Items
Cash Interest Paid	2.27M	2.27M	2.39M	2.38M	2.3M
Levered Free Cash Flow	114M	479M	-57.35M	-91.32M	361K
Unlevered Free Cash Flow	115M	481M	-55.65M	-89.66M	1.42M
Change In Net Working Capital	668K	-6.81M	8.58M	-132K	-1.1M
Net Debt Issued / Repaid	-	-	48.9M	-	-50M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.78	24.87	-2.14	-4.42	0.02
Return on Total Capital	7.8	24.96	-2.15	-4.43	0.02
Return On Equity %	13.21	42.01	-3.77	-7.78	-0.06
Return on Common Equity	13.21	42.01	-3.77	-7.78	-0.06
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	1.36	1.21	-1.02	-0.5	53.79
EBITA Margin %	98.15	98.69	102.08	101	17.44
EBIT Margin %	98.15	98.69	102.08	101	17.44
Income From Continuing Operations Margin %	96.86	98.37	105.76	102.86	-36.32
Net Income Margin %	96.86	98.37	105.76	102.86	-36.32
Net Avail. For Common Margin %	96.86	98.37	105.76	102.86	-36.32
Normalized Net Income Margin	60.54	61.48	66.1	64.29	-22.7
Levered Free Cash Flow Margin	60.18	62.37	77.73	64.2	12.12
Unlevered Free Cash Flow Margin	60.99	62.57	75.43	63.03	47.69
Asset Turnover
Asset Turnover	0.13	0.4	-0.03	-0.07	0
Short Term Liquidity
Current Ratio	1.6	0.1	2.64	0.11	3.1
Quick Ratio	1.6	0.1	2.64	0.11	3.1
Operating Cash Flow to Current Liabilities	-1.09	-0.05	-4.99	-0.02	-0.51
Long Term Solvency
Total Debt/Equity	6.87	4.64	7.5	8.42	5.83
Total Debt / Total Capital	6.43	4.43	6.97	7.76	5.51
LT Debt/Equity	6.87	2.31	7.5	5.6	5.83
Long-Term Debt / Total Capital	6.43	2.21	6.97	5.16	5.51
Total Liabilities / Total Assets	6.66	4.88	7.06	7.87	5.68
EBIT / Interest Expense	76.03	306.93	-27.72	-54.24	0.31
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-12.47	307.57	-109.6	92.79	-102.1
Gross Profit, 1 Yr. Growth %	-12.47	307.57	-109.6	92.79	-102.1
EBITA, 1 Yr. Growth %	-12.47	309.84	-109.93	90.76	-100.36
EBIT, 1 Yr. Growth %	-12.47	309.84	-109.93	90.76	-100.36
Earnings From Cont. Operations, 1 Yr. Growth %	-12.61	313.95	-110.32	87.51	-99.26
Net Income, 1 Yr. Growth %	-12.61	313.95	-110.32	87.51	-99.26
Normalized Net Income, 1 Yr. Growth %	-12.61	313.95	-110.32	87.51	-99.26
Diluted EPS Before Extra, 1 Yr. Growth %	-12.61	313.95	-110.32	87.51	-99.26
Accounts Receivable, 1 Yr. Growth %	3.85	-37.04	17.65	-20	275
Total Assets, 1 Yr. Growth %	9.14	45.72	-5.5	-9.98	-6.11
Tangible Book Value, 1 Yr. Growth %	9.9	48.5	-7.67	-10.76	-3.88
Common Equity, 1 Yr. Growth %	9.9	48.5	-7.67	-10.76	-3.88
Cash From Operations, 1 Yr. Growth %	45.79	-22.41	216.09	-87.37	32.38
Levered Free Cash Flow, 1 Yr. Growth %	-13.88	322.38	-111.96	59.22	-100.4
Unlevered Free Cash Flow, 1 Yr. Growth %	-13.72	318.14	-111.57	61.1	-101.59
Dividend Per Share, 1 Yr. Growth %	2.67	23.38	2.11	-22.68	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.81	88.87	-37.46	-56.98	-79.9
Gross Profit, 2 Yr. CAGR %	24.81	88.87	-37.46	-56.98	-79.9
EBITA, 2 Yr. CAGR %	25.09	89.4	-36.22	-56.49	-91.69
EBIT, 2 Yr. CAGR %	25.09	89.4	-36.22	-56.49	-91.69
Earnings From Cont. Operations, 2 Yr. CAGR %	25.57	90.19	-34.65	-56.01	-88.22
Net Income, 2 Yr. CAGR %	25.57	90.19	-34.65	-56.01	-88.22
Normalized Net Income, 2 Yr. CAGR %	25.57	90.19	-34.65	-56.01	-88.22
Diluted EPS Before Extra, 2 Yr. CAGR %	25.96	90.19	-34.65	-56.01	-88.2
Accounts Receivable, 2 Yr. CAGR %	-14.58	-19.14	-13.93	-2.99	73.21
Total Assets, 2 Yr. CAGR %	10.97	26.11	17.35	-7.77	-8.07
Tangible Book Value, 2 Yr. CAGR %	11.86	27.75	17.1	-9.23	-7.39
Common Equity, 2 Yr. CAGR %	11.86	27.75	17.1	-9.23	-7.39
Cash From Operations, 2 Yr. CAGR %	14.91	6.35	56.6	-36.81	-59.11
Levered Free Cash Flow, 2 Yr. CAGR %	25.9	90.72	-28.92	-56.36	-92.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.41	89.94	-30.45	-56.83	-84.02
Dividend Per Share, 2 Yr. CAGR %	4.88	12.55	12.24	-11.15	-12.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.82	85.17	-30.04	-8.98	-84.29
Gross Profit, 3 Yr. CAGR %	9.82	85.17	-30.04	-8.98	-84.29
EBITA, 3 Yr. CAGR %	9.97	85.79	-29.12	-8.1	-91.18
EBIT, 3 Yr. CAGR %	9.97	85.79	-29.12	-8.1	-91.18
Earnings From Cont. Operations, 3 Yr. CAGR %	10.13	86.88	-28	-7.13	-88.73
Net Income, 3 Yr. CAGR %	10.13	86.88	-28	-7.13	-88.73
Normalized Net Income, 3 Yr. CAGR %	10.13	86.88	-28	-7.13	-88.73
Diluted EPS Before Extra, 3 Yr. CAGR %	11.46	87.27	-28	-7.13	-88.72
Accounts Receivable, 3 Yr. CAGR %	-19.1	-22.84	-8.37	-16.01	52.25
Total Assets, 3 Yr. CAGR %	8.99	21.52	14.55	7.42	-7.22
Tangible Book Value, 3 Yr. CAGR %	9.76	22.94	14.65	6.96	-7.48
Common Equity, 3 Yr. CAGR %	9.76	22.94	14.65	6.96	-7.48
Cash From Operations, 3 Yr. CAGR %	34.37	0.81	52.91	-32.34	-19.15
Levered Free Cash Flow, 3 Yr. CAGR %	9.57	88.47	-24.22	-7	-90.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.42	87.36	-25.27	-7.97	-85.65
Dividend Per Share, 3 Yr. CAGR %	9.91	10.72	8.95	-0.87	-7.58
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-9.13	95.07	-12.32	3.27	-57.52
Gross Profit, 5 Yr. CAGR %	-9.13	95.07	-12.32	3.27	-57.52
EBITA, 5 Yr. CAGR %	-5.21	97.03	-11.56	3.96	-69.93
EBIT, 5 Yr. CAGR %	-5.21	97.03	-11.56	3.96	-69.93
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.63	99.71	-10.62	4.78	-65.1
Net Income, 5 Yr. CAGR %	-6.63	99.71	-10.62	4.78	-65.1
Normalized Net Income, 5 Yr. CAGR %	-6.63	99.71	-10.62	4.78	-65.1
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.16	103.55	-9.97	4.91	-65.07
Accounts Receivable, 5 Yr. CAGR %	-32.02	-20.64	-17.07	-15.44	18.2
Total Assets, 5 Yr. CAGR %	5.44	14.75	12.26	8.83	4.9
Tangible Book Value, 5 Yr. CAGR %	6.17	15.76	12.64	8.89	5.27
Common Equity, 5 Yr. CAGR %	6.17	15.76	12.64	8.89	5.27
Cash From Operations, 5 Yr. CAGR %	-23.24	-7.56	42.85	-16.37	-9.78
Levered Free Cash Flow, 5 Yr. CAGR %	-15.45	37.2	-7.85	4.98	-69.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-15.23	37.59	-8.72	4.16	-59.67
Dividend Per Share, 5 Yr. CAGR %	6.96	11.55	10.83	1.39	0